Eosinopenia in COVID-19: What we missed so far?
作者信息
Davido Benjamin, Partouche Bethsabee, Jaffal Karim, de Truchis Pierre, Herr Marie, Pepin Marion
机构信息
Maladies Infectieuses et Tropicales, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, AP-HP, Garches, 92380, France.
Gériatrie, Université Paris-Saclay, AP-HP Hôpital Ambroise Paré, AP-HP, Boulogne-Billancourt, 92100, France.
出版信息
J Microbiol Immunol Infect. 2021 Oct;54(5):1006-1007. doi: 10.1016/j.jmii.2021.01.013. Epub 2021 Feb 18.
Abstract
摘要
相似文献
1
Eosinopenia in COVID-19: What we missed so far?新冠病毒肺炎中的嗜酸性粒细胞减少症：我们目前遗漏了什么？
J Microbiol Immunol Infect. 2021 Oct;54(5):1006-1007. doi: 10.1016/j.jmii.2021.01.013. Epub 2021 Feb 18.
2
Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.嗜酸性粒细胞计数 <100/μL 作为 COVID-19 活动期的标志物：一项观察性前瞻性研究。
J Microbiol Immunol Infect. 2021 Feb;54(1):61-68. doi: 10.1016/j.jmii.2020.12.005. Epub 2021 Jan 8.
3
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.评价嗜酸性粒细胞减少症作为 COVID-19 感染的诊断和预后指标。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:137-141. doi: 10.1111/ijlh.13425. Epub 2020 Dec 8.
4
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.新冠肺炎患者疾病过程中恢复期和死亡患者嗜酸性粒细胞计数的变化。
Viruses. 2021 Aug 24;13(9):1675. doi: 10.3390/v13091675.
5
The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.COVID-19 中的系统性免疫反应与向无反应性甲酰肽的嗜酸性粒细胞转移有关。
Cells. 2021 May 5;10(5):1109. doi: 10.3390/cells10051109.
6
EOSINOPENIA: an early, effective and relevant COVID-19 biomarker?嗜酸性粒细胞减少：一种早期、有效的新冠病毒相关生物标志物？
QJM. 2021 Feb 18;114(1):68-69. doi: 10.1093/qjmed/hcaa259.
7
The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study.外周血嗜酸性粒细胞计数和嗜酸性粒细胞与淋巴细胞比值（ELR）对 COVID-19 患者临床病程的影响：一项回顾性研究。
In Vivo. 2021 Jan-Feb;35(1):641-648. doi: 10.21873/invivo.12303.
8
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.嗜酸性粒细胞减少可能是2019冠状病毒病患者的一个相关预后生物标志物。
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82. doi: 10.2500/aap.2020.41.200079.
9
Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic.在 2020 年大流行的第一波疫情期间，住院成人 COVID-19 感染过程中，嗜酸性粒细胞计数的正常化可预测氧脱机。
Front Immunol. 2024 May 24;15:1381059. doi: 10.3389/fimmu.2024.1381059. eCollection 2024.
10
Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.原创文章：评估嗜酸性粒细胞减少作为新型冠状病毒肺炎感染的诊断和预后指标
Int J Lab Hematol. 2021 Dec;43(6):e303. doi: 10.1111/ijlh.13573. Epub 2021 May 11.
引用本文的文献
1
Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic.在 2020 年大流行的第一波疫情期间，住院成人 COVID-19 感染过程中，嗜酸性粒细胞计数的正常化可预测氧脱机。
Front Immunol. 2024 May 24;15:1381059. doi: 10.3389/fimmu.2024.1381059. eCollection 2024.
2
Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe Illness.探索重症患者血浆脂联素、性别与基础疾病之间的关系。
Biomedicines. 2023 Dec 12;11(12):3287. doi: 10.3390/biomedicines11123287.
3
Off-Label Benralizumab in Severe Non-Necrotizing Eosinophilic Vasculitis following Critical COVID-19 Disease and in DRESS.重症新型冠状病毒肺炎后严重非坏死性嗜酸性血管炎及药物超敏反应伴嗜酸性粒细胞增多综合征中使用本瑞利珠单抗的超说明书用药情况
J Clin Med. 2022 Nov 9;11(22):6642. doi: 10.3390/jcm11226642.
4
Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker.持续性嗜酸性粒细胞减少与老年患者住院死亡率相关：重新审视的生物标志物的意外预后价值。
BMC Geriatr. 2021 Oct 14;21(1):557. doi: 10.1186/s12877-021-02515-0.
5
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.新冠肺炎患者疾病过程中恢复期和死亡患者嗜酸性粒细胞计数的变化。
Viruses. 2021 Aug 24;13(9):1675. doi: 10.3390/v13091675.
Zotero 插件